Centene Corp (CNC) Gets a Buy Rating from Morgan Stanley
In a report released today, Ricky Goldwasser from Morgan Stanley maintained a Buy rating on Centene Corp (CNC), with a price target of $64. The company’s shares closed last Monday at $45.55, close to its 52-week low of $45.44.
According to TipRanks.com, Goldwasser is a 4-star analyst with an average return of 4.3% and a 56.5% success rate. Goldwasser covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quest Diagnostics Inc, and Molina Healthcare.
Centene Corp has an analyst consensus of Strong Buy, with a price target consensus of $75.67.
See today’s analyst top recommended stocks >>
The company has a one-year high of $74.49 and a one-year low of $45.44. Currently, Centene Corp has an average volume of 6.04M.
Based on the recent corporate insider activity of 92 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CNC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid.